Artificial Intelligence in Drug Discovery, Pharmaceutical Processes, and Drug Delivery

Dear Colleagues,

The integration of Artificial Intelligence (AI) into pharmaceutical sciences is transforming the way therapeutics are discovered, developed, and delivered. AI-driven strategies are accelerating drug discovery through predictive modeling, molecular design, target identification, and data-guided optimization of candidate compounds. In pharmaceutical processes, machine learning and advanced analytics are enhancing manufacturing efficiency, improving quality control, and supporting real-time decision-making within complex production workflows. At the same time, AI is redefining drug delivery by enabling intelligent formulation design, personalized delivery systems, and optimized routes of administration based on patient-specific parameters.

This Special Issue invites original research articles, reviews that highlight cutting-edge advancements and practical applications of AI across the entire pharmaceutical pipeline. Contributions exploring computational methodologies, experimental validation, translational approaches, regulatory considerations, and ethical implications are especially encouraged. The objective is to provide an interdisciplinary platform showcasing the emerging potential of AI to reshape modern pharmaceutics and improve therapeutic outcomes.

We look forward to receiving your contributions.

Dr. Lisa Marinelli
Dr. Ivana Cacciatore
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.